Ligand Pharma (LGND) PT Lowered to $180 at Roth Capital

February 10, 2020 5:41 AM EST Send to a Friend

Roth Capital analyst Scott Henry ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Ligand Pharma (LGND) PT Lowered to $180 at Roth Capital

Member Login

Free News Feed